These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27756332)

  • 21. The impact of androgen levels on serum metabolic profiles in patients with polycystic ovary syndrome.
    Ting Z; Xinghua T; Xiao X; Lingchuan L; Xiaomei W; Tao Y
    Gynecol Endocrinol; 2024 Dec; 40(1):2352136. PubMed ID: 38733359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.
    Alemzadeh R; Kichler J; Calhoun M
    Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran.
    Tehrani FR; Rashidi H; Khomami MB; Tohidi M; Azizi F
    Reprod Biol Endocrinol; 2014 Sep; 12():89. PubMed ID: 25224635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dyslipidemia involvement in the development of polycystic ovary syndrome.
    Liu Q; Xie YJ; Qu LH; Zhang MX; Mo ZC
    Taiwan J Obstet Gynecol; 2019 Jul; 58(4):447-453. PubMed ID: 31307731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of the efficacy of ω-3 polyunsaturated fatty acids when treating patients with polycystic ovary syndrome.
    Huang Y; Zhang X
    Medicine (Baltimore); 2023 Sep; 102(39):e35403. PubMed ID: 37773824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
    Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F
    Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic inflexibility in women with polycystic ovary syndrome: a systematic review.
    Rimmer M; Tan BK; Teede H; Thangaratinam S; H Al Wattar B
    Gynecol Endocrinol; 2020 Jun; 36(6):501-507. PubMed ID: 31793357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PCOS without hyperandrogenism is associated with higher plasma Trimethylamine N-oxide levels.
    Huang J; Liu L; Chen C; Gao Y
    BMC Endocr Disord; 2020 Jan; 20(1):3. PubMed ID: 31906930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis.
    Chien YJ; Chang CY; Wu MY; Chen CH; Horng YS; Wu HC
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-invasive urinary metabolomics reveals metabolic profiling of polycystic ovary syndrome and its subtypes.
    Zhou W; Hong Y; Yin A; Liu S; Chen M; Lv X; Nie X; Tan N; Zhang Z
    J Pharm Biomed Anal; 2020 Jun; 185():113262. PubMed ID: 32222648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of cinnamon on controlling metabolic parameters of polycystic ovary syndrome: A systematic review and meta-analysis.
    Heydarpour F; Hemati N; Hadi A; Moradi S; Mohammadi E; Farzaei MH
    J Ethnopharmacol; 2020 May; 254():112741. PubMed ID: 32151755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of the triglyceride-glucose index and non-traditional blood lipid parameters in predicting metabolic syndrome in women with polycystic ovary syndrome.
    Zhang L; Wang H; Ma Q; Liu Y; Chen A; Lu J; Ren L
    Hormones (Athens); 2023 Jun; 22(2):263-271. PubMed ID: 36790635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular and metabolic characteristics of infertile Chinese women with PCOS diagnosed according to the Rotterdam consensus criteria.
    Guo M; Chen ZJ; Macklon NS; Shi YH; Westerveld HE; Eijkemans MJ; Fauser BC; Goverde AJ
    Reprod Biomed Online; 2010 Oct; 21(4):572-80. PubMed ID: 20800551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
    Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
    Chen Y; Wang XJ; Jin HL; Jin L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):751-6. PubMed ID: 23980352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance.
    Jones H; Sprung VS; Pugh CJ; Daousi C; Irwin A; Aziz N; Adams VL; Thomas EL; Bell JD; Kemp GJ; Cuthbertson DJ
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3709-16. PubMed ID: 22837189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.